Initiation of research

REACH non-regulatory announcement

3 November 2025

MedPal AI plc

(the "Company" or "MedPal AI")

Initiation of Research by Optimo Research

MedPal AI plc (AIM:MPAL), a UK-based digital health and artificial intelligence (AI) company is pleased to announce the initiation of research by Optimo Capital Limited's research arm, Optimo Research Ltd ("Optimo Research").

The research is available on the Optimo Research website here:

https://www.optimocapital.co.uk/library-2

For further information please visit www.medpalplc.com or contact:

MedPal AI plc via Square1 Consulting

Jason Drummond, Chief Executive Officer

Clear Capital Markets Limited +44 20 3869 6080

Bob Roberts/ Nick Josh

Square1 Consulting +44 20 7929 5599

David Bick +44 7831 381201

About MedPal AI

MedPal AI is a UK-based digital health company specialising in AI-driven wellness management. Its core app aggregates data from over 100 wearable health trackers and apps (eg. Apple Health, Fitbit or Garmin) into a unified profile, offering non-clinical, personalised lifestyle guidance through its AI wellness coach. The Company is also developing conversational AI to provide voice-based, real-time health Insights, alerts and recommendations.

MedPal AI recently acquired a complementary automated pharmacy facility, operating under an NHS Distance Selling Pharmacy licence, to deliver timely, affordable access to medicine and telehealth pathways across the UK.

Visit our website: www.medpalplc.com

Follow us on social media:

X: @MedPalPlc

LinkedIn: MedPal AI plc

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only/non-regulatory news releases Into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or any other regulation would be disseminated as an RNS regulatory announcement and not on Reach.